RT Journal Article
SR Electronic
T1 Characterization of the Second Wave of the COVID-19 Pandemic in India: A Google Trends Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.19.21257473
DO 10.1101/2021.05.19.21257473
A1 Visaria, Aayush
A1 Polamarasetti, Pooja
A1 Reddy, Shivani
A1 Ali, Alizah
A1 Hameed, Fariha R.
A1 James, Joel
A1 Akhtar, Moizz
A1 Islam, Sumaiya
A1 Raju, Priyanka
A1 Thawani, Rajat
YR 2021
UL http://medrxiv.org/content/early/2021/05/21/2021.05.19.21257473.abstract
AB Background The second wave of the COVID-19 pandemic has led to considerable morbidity and mortality in India, in part due to lack of healthcare access, low health literacy, and poor disease surveillance. In this retrospective, descriptive ecological study, we utilized Google Trends (GT) to characterize the second COVID-19 wave and its association with official case counts based on search terms related to symptoms, testing, disease complications, medications, preventive behaviors, and healthcare utilization.Methods GT is a publicly available, online tracking system of Google searches. Searches are presented as relative search volumes (RSV) from 0 (least) to 100 (most number of searches). We performed pre-defined Web searches in India from 2/12/2021 to 5/09/2021. We characterized the peak RSV, RSV doubling rates, and Spearman rank correlation of selected search terms with official case counts. We also used date-adjusted linear regression to estimate the association between highly correlated search terms and official case counts. We then qualitatively classified public search queries into thematic groups to better understand public awareness and needs related to COVID-19.Results We observed that searches for symptoms (most searched terms in order: fever, cough, headache, fatigue, chest pain), disease states (infection, pneumonia), COVID-19-related medications (remdesivir, ivermectin, azithromycin, Fabiflu, dexamethasone), testing modalities (PCR, CT Scan, D-dimer, C-reactive protein, oxygen saturation), healthcare utilization (oxygen cylinders, hospital, physician), and preventive behaviors (lockdown, mask, pulse oximetry, hand sanitizer, quarantine) all demonstrated increases, in line with increases in official case counts. Symptoms, PCR testing, outpatient medications, and preventive behaviors peaked around April 24th, approximately two weeks prior to the peak RSV in official case counts. Contrarily, healthcare utilization factors, including searches for hospital, physicians, beds, disease states, and inpatient medications did not peak until the first week of May. There were highly significant correlations between ‘Coronavirus Disease 2019’ (r=0.959), ‘fever’ (r=0.935), ‘pulse oximetry’ (r=0.952), ‘oxygen saturation’ (r=0.944), ‘C-reactive protein’ (r=0.955), ‘D-Dimer’ (r=0.945), & ‘Fabiflu’ (r=0.943) and official case counts.Conclusion GT search terms related to symptoms, testing, and medications are highly correlated with official case counts in India, suggesting need for further studies examining GT’s potential use as a disease surveillance and public informant tool for public health officials.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was exempt from Rutgers University IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available on trends.google.com. Our specific CSV file used for analysis can be provided upon reasonable request. https://trends.google.com